IPO News Live Updates: Latest on IPOs, Subscription Status, GMP & Allotment – December 26, 2024

IPO News Today Live Updates:

Stay updated with the latest news and insights on Initial Public Offerings (IPOs) as companies enter the public market. Our dedicated IPO News section covers everything from IPO timelines, pricing, and subscription status to post-listing performance and market reception. Whether you're an investor seeking new opportunities or just interested in the financial markets, we provide essential information on IPOs and their impact on the stock exchange. Understand the factors and trends influencing companies’ decisions to go public in the current economic climate.

IPO News Today Live:

Unimech Aerospace IPO Day 3 – GMP, Subscription Status, and Should You Apply?

The IPO of Unimech Aerospace and Manufacturing Limited opened on December 23, 2024, and will close on December 26, 2024. The company has set a price band of ₹745 to ₹785 per share, aiming to raise ₹500 crore through a mix of fresh shares and an offer for sale (OFS). The IPO has received a positive response so far, with the issue being subscribed 9.09 times in the first two days. The retail portion was oversubscribed 10.30 times, while the non-institutional investors (NII) segment saw a subscription of 12.07 times. The Qualified Institutional Buyers (QIB) segment was subscribed 4.64 times.

Grey Market Premium (GMP)

Shares of Unimech Aerospace are currently trading at a premium of ₹511 in the grey market. This implies that the expected listing price could be around ₹1296 (₹785 + ₹511), which is approximately 65% higher than the upper price band of ₹785.

IPO Review

Experts have given positive reviews to the IPO. Hem Securities has recommended a "Subscribe" rating, highlighting the company's global presence in the aerospace, defense, semiconductor, and energy sectors, and its strong manufacturing capabilities. Marwadi Shares and Finance also assigned a "Subscribe" rating, noting the company's reasonable valuation compared to peers like MTAR Technologies, Azad Engineering, and others. Analysts view Unimech Aerospace’s advanced manufacturing abilities and strong market position as key positives for potential investors.

Conclusion

The IPO is generating strong interest, with a solid grey market premium and a positive response from investors. Leading financial analysts have also recommended subscribing to the issue based on the company's growth potential and reasonable valuation relative to industry peers.

Ventive Hospitality IPO Allotment Status – GMP, How to Check Allotment Online

The initial public offering (IPO) of Ventive Hospitality Ltd, which closed on December 24, 2024, has seen strong subscription interest. The IPO, which aimed to raise ₹1,600 crore, was open for subscription from December 20 to December 24. The price band was set at ₹610 to ₹643 per share, and the IPO was oversubscribed 9.82 times, with strong demand from non-institutional investors and qualified institutional buyers.

IPO Allotment Status

The allotment status for the Ventive Hospitality IPO is expected to be finalized today, December 26. Once the allotment is complete, eligible applicants will have shares credited to their Demat accounts, and unsuccessful bidders will receive refunds.

Investors can check the allotment status through the BSE and NSE websites, or by visiting the official IPO registrar portal, Kfin Technologies.

How to Check Allotment Status

BSE: Visit the BSE website, select 'Ventive Hospitality Limited,' and enter your application number or PAN to check the status.

Kfin Technologies: Go to the registrar's website, select 'Ventive Hospitality Limited,' and enter your application number, Demat account, or PAN to view the status.

Grey Market Premium (GMP)

The IPO is currently commanding a grey market premium (GMP) of ₹72, indicating that the shares are trading at a premium in the grey market. This suggests an estimated listing price of ₹715 per share, an 11.2% gain over the issue price of ₹643.

IPO Subscription Details

The IPO received bids for 14.17 crore shares against an issue size of 1.44 crore shares. The retail portion was subscribed 5.94 times, the NII segment saw a 13.87 times subscription, and the QIB portion was subscribed 9.08 times.

The IPO is expected to be listed on the BSE and NSE on December 30, 2024.

Conclusion

With strong subscription numbers and a solid GMP, the Ventive Hospitality IPO is expected to have a positive debut. Investors can now check the allotment status online and prepare for the listing on December 30.

Senores Pharmaceuticals IPO Allotment: Key Updates

The allotment for the Senores Pharmaceuticals IPO is expected to be finalized today, December 26, 2024. The IPO, which closed on December 24, 2024, garnered significant interest from investors.

IPO Subscription Details

The ₹582.11 crore public offering, priced between ₹372 and ₹391 per share, was oversubscribed by 93.69 times. The highest demand came from Non-Institutional Investors (NIIs), who subscribed 96.30 times their allocated quota, followed by Qualified Institutional Buyers (QIBs) at 94.66 times, and Retail Individual Investors (RIIs) at 90.46 times their respective quotas.

How to Check Allotment Status

Once the allotment is finalized, investors can check their status on the following platforms:

- BSE: https://www.bseindia.com/investors/appli_check.aspx

- Link Intime India: https://linkintime.co.in/initial_offer/public-issues.html

- NSE: https://www.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp

Grey Market Premium (GMP)

Senores Pharmaceuticals IPO is currently trading at a grey market premium (GMP) of ₹240, indicating a potential listing price of ₹631 per share, 61.38% higher than the upper price band of ₹391.

IPO Listing Date

Senores Pharmaceuticals shares are expected to list on the BSE and NSE on December 30, 2024. If the current GMP holds, the shares may debut at around ₹631 per share, though these estimates are subject to market fluctuations.

About Senores Pharmaceuticals

Senores Pharmaceuticals is a research-driven pharmaceutical company focused on developing products for regulated markets in the US and Canada. Since its incorporation in 2017, the company has launched 55 products, with a strong presence in key therapeutic areas such as antibiotics and antifungal treatments. The company operates in 43 countries and manufactures critical care injectables and APIs.

Carraro India IPO Allotment and Key Details

The allotment for Carraro India IPO is expected to be finalized today or tomorrow morning. Shares will be allotted on a lottery basis, and the entire process will be supervised by the registrar. Investors will be informed about the number of shares allotted to them compared to their bids.

How to Check Allotment Status

Investors can check their allotment status through the BSE or registrar's website. Here's how:

- On BSE:

1. Visit the BSE website https://www.bseindia.com/investors/appli_check.aspx.

2. Select "Carraro India" from the dropdown menu.

3. Enter either the application number or PAN to check the status.

- On Link Intime India (Registrar):

1. Visit https://linkintime.co.in/initial_offer/.

2. Select "Carraro India IPO" from the dropdown.

3. Enter PAN details and click "Search."

Carraro India IPO Grey Market Premium (GMP)

The shares of Carraro India are trading at a grey market premium (GMP) of ₹0, indicating no premium over the issue price, implying a 0% gain for the IPO.

Carraro India IPO Subscription

The IPO was subscribed 1.18 times by the close of the bidding process.

Company Overview

Carraro India manufactures components ranging from small gears to complete tractor assemblies. They design and produce transmission systems for agricultural and construction vehicles. With two manufacturing plants in Pune, the company has seen a 4% rise in revenue from ₹1,695 crore in FY23 to ₹1,770 crore in FY24. Their profit after tax increased by 29%, reaching ₹60.58 crore during the same period.

Listing Date

Carraro India shares are expected to be listed on the exchanges on December 30, 2024.